STARPLUS LEGEND

Star Plus Legend opened higher and climbed steadily in the morning session, up 6.47% to HK$4.28 as of 10:12 BJ, with an intraday high of HK$4.29. The stock has rebounded about 8.9% from its 52-week low of HK$3.93 but remains down 28.43% YTD and 72.14% below the 52-week high of HK$15.36. It now trades above the 20-day MA (HK$4.138) but below the 60-day MA (HK$4.799). The rally was driven by approval of audited FY2025 financials at the AGM, alongside prior gains of over 8% on AI partnership and shareholder approval news. However, fundamentals remain weak: Q4 2025 revenue plunged 61.18% YoY to HK$65.55 million, net profit turned to a loss of HK$25.94 million, with EPS of -HK$0.0284. The stock trades at a PE of -101.13x and PB of 2.35x, warranting caution on earnings recovery.

Star Plus Legend (6683.HK) opened lower and extended losses in the afternoon session, closing at HK$3.93, down 5.07% and hitting a new 52-week low. The stock initially surged to an intraday high of HK$4.23 in the morning session before sharply reversing, with the session's low of HK$3.93 recorded in the afternoon, representing a 7.1% intraday range. The company's Q4 2025 operating revenue plunged 61.18% YoY to HK$65.55 million, with a net loss of HK$25.94 million and EPS of -HK$0.0284, as deteriorating fundamentals continued to weigh on the stock. Currently trading 74.41% below its 52-week high of HK$15.36 and down 34.28% year-to-date, the stock also sits well below its MA20 (HK$4.161) and MA60 (HK$4.876). However, the stock had previously surged over 8% in a single session on AGM-related news, indicating short-term sentiment can be volatile.

Star Plus Legend opened lower and then rebounded in the morning session, closing up 5.17% at HKD 4.270 after hitting an intraday low of HKD 4.040, a new 52-week low, as news of shareholder approval of the 2025 audited financial statements at the AGM catalyzed a recovery of over 5.7% from the day's trough. The company's fundamentals remain under pressure, with Q4 2025 operating revenue falling 61.18% YoY to HKD 65.55 million and net loss widening 256.83% YoY to HKD 25.94 million, resulting in a negative P/E ratio. The stock is down 75.79% from its 52-week high of HKD 17.640 and has declined 28.6% year-to-date; while it has reclaimed the 20-day moving average (HKD 4.246), it still trades below the 60-day MA (HKD 5.050), indicating a weak overall position. Turnover, however, expanded to HKD 15.82 million, showing increased trading activity.

Giant Legend opened at HK$4.19 in the morning session and traded lower throughout, closing at HK$4.03, down 5.18%. The intraday low of HK$4.03 sits just 0.5% above its 52-week low, while the stock has lost 32.61% year-to-date. The decline was driven by persistently deteriorating earnings: Q4 2025 operating revenue plunged 61.18% YoY to HK$65.5 million, and net loss widened 256.83% YoY to HK$25.9 million, with EPS of -HK$0.0284 and a net profit margin of -39.56%. Recent news flow, including shareholder approval of audited financials and an AI partnership announcement, failed to offset the weak fundamentals. The stock remains below both its 20-day (HK$4.258) and 60-day (HK$5.077) moving averages.

Star Plus Legend reversed early losses to close the morning session up 5.11% at HK$4.32, recovering from an open of HK$4.11 to hit an intraday high of HK$4.32 on volume of 2.45 million shares and turnover of HK$10.38 million. The bounce was driven by continued positive sentiment from the AGM's approval of the 2025 audited financials and an AI-powered skincare and health ecosystem partnership with Park Ha Biological. However, the company's Q4 2025 results showed revenue plunged 61.18% YoY to HK$65.55 million, with a net loss of HK$25.94 million and EPS of -HK$0.0284, marking a sharp earnings reversal. At HK$4.32, the stock remains 75.51% below its 52-week high of HK$17.64, down 27.76% year-to-date, and trades below the 60-day MA of HK$5.11, indicating persistent weakness despite the short-term rally.